1. What is the metric?

Prevalence of Antianxiety/Hypnotic Use  (Long Stay)

  1. What does the metric mean?

This measure reports the percentage of long-stay residents who are receiving antianxiety medications or hypnotics but do not have evidence of psychotic or related conditions in the target period. 

  1. How do we calculate the metric?

    1. The Numerator is the number of long-stay residents with a selected target assessment where the following condition is true: 

      1. Antianxiety medications received (N0415B1 = [1]), or

      2. Hypnotic medications received (N0415D1 = [1])

    2. The Denominator is all long-stay residents with a selected target assessment, except those with exclusions.

    3. Exclusions include:

      1. The resident did not qualify for the numerator

      2. Items for the numerator are missing on the target assessment

      3. The resident has any of the following conditions on the target assessment: Anxiety, PTSD, Schizophrenia, Tourette's, Psychotic Disorder, Bipolar Disorder, Huntington Disease, Delusions, Hallucinations

      4. The resident has any of the following conditions on the prior assessment: PTSD or Tourette's if this item is not active on the target assessment and if a prior assessment is available

References 

MDS 3.0 Quality Measures User's Manual V16 

Page 55, Table 2-33

For assessments with an ARD prior to 10/01/2023:

MDS 3.0 Quality Measures User’s Manual V15

Page 56, Table 2-31